FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Sonoma Pharmaceuticals, Inc. Rises 60% Following Launch of OTC Products on Amazon”
Sonoma Pharmaceuticals, Inc (NASDAQ: SNOA) surged 60% in premarket trading after the company announced its 3 new over the counter products based on Sonoma’s patented Microcyn® technology
The over-the-counter consumer launch of Regenacyn® Advanced Scar Gel and Ocucyn® Eyelid & Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn® technology more widely available.
Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions.
For more information, please visit: Sonoma Pharmaceuticals
About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.